These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20979785)

  • 1. [The efficacy and safety of long-term thalidomide in the treatment of ankylosing spondylitis].
    Zhu J; Huang F; Zhang JL
    Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):667-70. PubMed ID: 20979785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide for severe refractory ankylosing spondylitis: a 6-month open-label trial.
    Wei JC; Chan TW; Lin HS; Huang F; Chou CT
    J Rheumatol; 2003 Dec; 30(12):2627-31. PubMed ID: 14719205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of thalidomide on psychological symptoms and sleep disturbances in the patient with refractory ankylosing spondylitis.
    Zhang S; Chen Z; Wu Y; Lin D; He J; Liu J; Gao F; Lin H
    Ann Palliat Med; 2021 Mar; 10(3):2512-2519. PubMed ID: 33474948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year open-label trial of thalidomide in ankylosing spondylitis.
    Huang F; Gu J; Zhao W; Zhu J; Zhang J; Yu DT
    Arthritis Rheum; 2002 Jun; 47(3):249-54. PubMed ID: 12115153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS).
    Revicki DA; Luo MP; Wordsworth P; Wong RL; Chen N; Davis JC;
    J Rheumatol; 2008 Jul; 35(7):1346-53. PubMed ID: 18484692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of etanercept for treating ankylosing spondylitis].
    Liang LQ; Zhan ZP; Ye YJ; Fu D; Xu HS; Yang XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1349-51. PubMed ID: 18753057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
    van der Heijde D; Dijkmans B; Geusens P; Sieper J; DeWoody K; Williamson P; Braun J;
    Arthritis Rheum; 2005 Feb; 52(2):582-91. PubMed ID: 15692973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical research for curing ankylosing spondylitis through combining etanercept, thalidomide and sulfasalazine.
    Xiao P; Pang C; Zhu X; Wu X
    Pak J Pharm Sci; 2015 Jan; 28(1 Suppl):359-62. PubMed ID: 25631513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial.
    Braun J; Brandt J; Listing J; Zink A; Alten R; Burmester G; Golder W; Gromnica-Ihle E; Kellner H; Schneider M; Sörensen H; Zeidler H; Reddig J; Sieper J
    Arthritis Rheum; 2003 Aug; 48(8):2224-33. PubMed ID: 12905476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis.
    Pathan E; Abraham S; Van Rossen E; Withrington R; Keat A; Charles PJ; Paterson E; Chowdhury M; McClinton C; Taylor PC
    Ann Rheum Dis; 2013 Sep; 72(9):1475-80. PubMed ID: 22984171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A short-term efficacy and safety study of infliximab in active ankylosing spondylitis].
    Huang F; Zhang LY; Zhang JL; Zhang FC; Liang DF; Deng XH; Guo JH; Zhu J; Zhao W; Li XF; Hou Y
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):122-6. PubMed ID: 16624120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.
    Brandt J; Listing J; Haibel H; Sörensen H; Schwebig A; Rudwaleit M; Sieper J; Braun J
    Rheumatology (Oxford); 2005 Mar; 44(3):342-8. PubMed ID: 15561737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy and safety of multiple intravenous infusions of infliximab in refractory ankylosing spondylitis patients with axial involvement.
    Rejón E; Giménez MD; Mayordomo L; Rodríguez S; González MP; Marenco JL
    Scand J Rheumatol; 2004; 33(5):323-6. PubMed ID: 15513681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations.
    Song IH; Rudwaleit M; Listing J; Sieper J
    Ann Rheum Dis; 2009 Nov; 68(11):1701-7. PubMed ID: 19029168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose amitriptyline in ankylosing spondylitis: a short term, double blind, placebo controlled study.
    Koh WH; Pande I; Samuels A; Jones SD; Calin A
    J Rheumatol; 1997 Nov; 24(11):2158-61. PubMed ID: 9375877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data.
    Baraliakos X; Brandt J; Listing J; Haibel H; Sörensen H; Rudwaleit M; Sieper J; Braun J
    Arthritis Rheum; 2005 Dec; 53(6):856-63. PubMed ID: 16342093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Swedish version of the Bath ankylosing spondylitis disease activity index. Reliability and validity.
    Waldner A; Cronstedt H; Stenström CH
    Scand J Rheumatol Suppl; 1999; 111():10-6. PubMed ID: 10503554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis.
    Rudwaleit M; Schwarzlose S; Hilgert ES; Listing J; Braun J; Sieper J
    Ann Rheum Dis; 2008 Sep; 67(9):1276-81. PubMed ID: 18006539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.
    Maksymowych WP; Jhangri GS; Fitzgerald AA; LeClercq S; Chiu P; Yan A; Skeith KJ; Aaron SL; Homik J; Davis P; Sholter D; Russell AS
    Arthritis Rheum; 2002 Mar; 46(3):766-73. PubMed ID: 11920413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis].
    Grazio S; Grubisić F; Nemcić T; Matijević V; Skala H
    Reumatizam; 2009; 56(2):63-76. PubMed ID: 20429263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.